Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VENTAVIS for Cor pulmonale chronic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where VENTAVIS was used for Cor pulmonale chronic.

Most Reported Side Effects for VENTAVIS

Side Effect Reports % Deaths Hosp.
Dyspnoea 63 17.0% 26 47
Death 62 16.7% 62 25
Pulmonary arterial hypertension 40 10.8% 27 27
Fatigue 26 7.0% 9 18
Malaise 26 7.0% 10 17
Pneumonia 26 7.0% 8 25
Drug dose omission 21 5.7% 7 21
Headache 21 5.7% 4 12
Fluid retention 19 5.1% 9 17
Pulmonary hypertension 18 4.9% 15 12
Asthenia 17 4.6% 6 12
Cough 17 4.6% 4 9
Fall 17 4.6% 3 15
General physical health deterioration 17 4.6% 12 11
Oedema peripheral 17 4.6% 5 14

Other Indications for VENTAVIS

Pulmonary arterial hypertension (238) Pulmonary hypertension (63) Product used for unknown indication (31)

Other Drugs Used for Cor pulmonale chronic

TREPROSTINIL (1,407) AMBRISENTAN (879) MACITENTAN (254) EPOPROSTENOL (239) BOSENTAN\BOSENTAN (238) REMODULIN (220) TYVASO (143) TRACLEER (101) ILOPROST (65) BOSENTAN (60)

Related Pages

VENTAVIS Full Profile All Cor pulmonale chronic Drugs VENTAVIS Demographics VENTAVIS Timeline